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Icariin, a prenylated flavonol glycoside isolated from Epimedium, has been considered as a potential 
alternative therapy for osteoporosis. The present study aimed to clarify the detailed molecular mechanisms 
of action of icariin on osteoblast function, using bone marrow-derived mesenchymal stem cells 
(BM-MSCs). BM-MSCs were first stimulated by icariin. Then, gene and protein expression of cAMP/
PKA/CREB signaling molecules were analyzed by RT-PCR and western blotting (WB), and alkaline 
phosphatase (ALP) was analyzed in cell lysates by ELISA. MTT assays indicated that icariin did not 
have significant effects on cell viability up to 1 μM. Icariin showed a dose-dependent effect on the 
alkaline phosphatase activity of BM-MSCs. WB analysis showed that icariin treatment of BM-MSCs 
significantly enhanced the protein expression of protein kinase A (PKA) and cAMP-responsive element 
binding protein (CREB), while RT-PCR results showed that icariin dose-dependently increased the 
mRNA levels of PKA and CREB. Icariin induced BM-MSC differentiation by BMP2, Smad1, and Runx2. 
RT-PCR and WB results indicated that icariin significantly increased the expression of BMP2, Smad1, and 
Runx2 in BM-MSCs. These results suggest that icariin is an agonist of the cAMP/PKA/CREB pathway 
in BM-MSC differentiation, raising the possibility that it could be used in the treatment of osteoporosis.
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INTRODUCTION
Osteoporosis is characterized by low bone 
mineral density (BMD) and loss of the structural and 
biomechanical properties that are required to maintain 
bone homeostasis (Ivanova et al., 2015). Icariin is the 
main active flavonoid glucoside of Epimedium pubescens, 
which has been reported to enhance bone healing and 
reduce the incidence of osteoporosis (Hsieh et al., 2010). 
Icariin restores the osteogenic differentiation and bone 
formation of bone marrow stromal cells in a rat model 
of estrogen deficiency-induced osteoporosis (Luo et al., 
2015). In the ovariectomized (OVX) calvarial defect 
model, icariin loaded on CPC scaffolds enhanced both 
osteogenesis and angiogenesis, while a system of local 
sustained release of icariin combined with systemic 
administration achieved a better effect on bone defect 
regeneration (Wu et al., 2017). 
Osteoblasts, osteocytes and osteoclasts are the 
three types of bone cells that are in direct contact with 
all the cellular elements in the bone marrow (Carrington, 
2005). Mesenchymal stem cells (MSCs) are a promising 
source of cells for use in cell-based therapeutics and 
regenerative medicine due to their ability to self-renew 
and differentiate into a number of functional cell types. 
To date, bone marrow-derived mesenchymal stem cells 
(BM-MSCs) have been the most widely-studied family of 
stem cells (Li et al., 2016). BM-MSCs have been estimated 
to represent 0.01–0.0001% of the nucleated cells in adult 
human bone marrow (Dazzi et al., 2006). BM-MSCs 
are progenitors of skeletal tissue components such as 
bone, cartilage, the hematopoiesis-supporting stroma, 
and adipocytes (Bianco, Riminucci, Gronthos, 2001). 
Bone morphogenesis protein-2 (BMP-2), a member of 
the BMP family, is one of the best-characterized inducers 
of osteochondrogenesis and can increase the expression 
of markers of both osteo- and chondrogenic lineage 
differentiation of progenitor cells, such as MSCs. It has 
recently been shown that protein kinase A (PKA) activation 
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also forms an important component of the mechanism 
by which BMP-2 mediates MSC differentiation. Once 
activated, PKA usually phosphorylates its prototypical 
downstream transcription factor, cAMP-responsive 
element binding protein (CREB), which is associated with 
a number of important physiological functions including 
osteochondrogenic differentiation (Zhao, Li, Zhou, 2009). 
Icariin has been shown to have an anti-osteoporotic 
effect by regulating the bidirectional differentiation of 
BM-MSCs through the canonical Wnt signaling pathway 
(Huang et al., 2017). Icariin is also a bone anabolic 
agent that may exert its osteogenic effects through the 
induction of BMP-2 and NO synthesis, subsequently 
regulating expression of Cbfa1/Runx2, OPG, and 
RANKL. This effect may contribute to its effect on the 
induction of osteoblast proliferation and differentiation, 
resulting in bone formation (Hsieh et al., 2010). In this 
study, we clarified the detailed molecular mechanisms 
of action of icariin on the osteoblastic function of BM-
MSCs. The results demonstrate that icariin induces 
osteoblast differentiation via BMP2, through activation of 
cAMP/PKA/CREB signaling in osteoblasts. 
MATERIAL AND METHODS
Material and reagents 
Icariin was obtained from Sigma-Aldrich (St. Louis, 
MO, USA) and the purity of the compound was more than 
99%. Stock solutions of icariin were prepared in dimethyl 
sulfoxide (DMSO) (Sigma-Aldrich). In all studies, the 
final concentration of DMSO was 0.1% (v/v). The icariin 
stock solutions were stored at -20 ºC.
Cell culture 
BM-MSCs were purchased from Saiye Biological 
Technology Co., Ltd. (Guangzhou, China). BM-MSCs 
were cultured in 25 cm2 flasks in complete medium 
(DermaLife® K Medium Kit, Lifeline Cell Technology, 
Frederick, MD, USA) consisting of DMEM, 10% fetal 
bovine serum (FBS), and 100 U/mL penicillin and 
streptomycin. Cells were trypsinized and passaged 
at 80-90% confluence. The cells were reseeded into 
96-well plates or 6-well plates at a density of 1 × 104 
or 1 × 106 cells/well, respectively, and cultured in a 
humidified atmosphere of 5% CO2 and 95% air, at 37ºC.
Cell viability assay
BM-MSCs were plated into 96-well plates at a 
density of 1 × 104 per well. After 2 days, cells were 
stimulated with icariin at concentrations of 0, 0.001, 
0.01, 0.1, 1 or 10 μM for 24 h. Cell proliferation was 
investigated using the 3-(4, 5-dimethylthiazolyl-2)-2, 
5-diphenyltetrazolium bromide (MTT) assay. To perform 
the assay, 20 μL of MTT was added to every well, and the 
plates were placed into a 5% CO2-humidified incubator at 
37ºC for 4 h. After incubation, supernatants were removed 
from the plates and 100 μL of DMSO solution was added 
for 15 min. The plates were read on a micro-plate reader 
at a wavelength of 492 nm.
RNA preparation and RT-PCR analysis
BM-MSCs were seeded into 6-well plates at a density 
of 1 × 106 cells per well. Total RNA was extracted from the 
cells using TRIzol® reagent according to the manufacturer’s 
instructions (Life Technologies, Carlsbad, CA, USA) after 
stimulation. First strand cDNA was synthesized using 
a Reverse Transcription System Kit (Tiangen Biotech, 
Beijing, China). RNA was reverse transcribed into cDNA 
and analyzed by RT-PCR using an ABI PRISM® 7000 
sequence detector (Applied Biosystems, Foster City, CA, 
USA). CREB, PKA, BMP2, Smad1, and Runx2 mRNA 
levels were detected by real-time PCR in a reaction 
mixture of 20 μL total volume containing 10 μL of 2 × 
SYBR® TransStar Green PCR Super Mix, 0.6 μL sense and 
antisense primers, and 50 ng RT product. The utilized primer 
sequences are shown in Table I. 
TABLE I - Primer for real-time PCR assays
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Western blot analysis
Cells were lysed with lysis buffer (20 mM Tris-
HCl, pH 8.0, 120 mM NaCl, 1% [v/v] Triton™ X-100, 
10 mM ethylenediaminetetraacetic acid, 1 mM ethylene 
glycol tetraacetic acid, 0.05% [v/v] 2-mercaptoethanol, 
and 1 × protease inhibitor solution). Cell debris was 
removed by centrifugation at 14,000 × g for 15 min, and 
equal amounts of protein extracted from each sample were 
heat denatured and subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% 
(v/v) polyacrylamide gel. After electrophoresis, proteins 
were electrotransferred onto polyvinylidene difluoride 
membranes. The membranes were blocked with 5% (w/v) 
skimmed milk at room temperature for 2 h and probed 
with primary antibody at 4°C overnight. The primary 
antibodies used were CREB, PKA, BMP2, Smad1, and 
RUNX2. After washing, membranes were incubated with 
the appropriate secondary antibody in 5% (w/v) skimmed 
milk/Tris-buffered saline containing 0.05% Tween® 20 for 
1 h at 4°C. Proteins were detected using SignalFire™ ECL 
Reagent (Cell Signaling Technology, Danvers, MA, USA).
Enzyme-linked immunosorbent assay (ELISA) 
analysis
Supernatants from BM-MSC cell culture were 
harvested at 24 h after stimulation, and centrifuged at 
1000 × g for 20 min. The supernatants were analyzed for 
ALP by ELISA following the manufacturers’ instructions 
(Nanjing Jiancheng Bioengineering Institute).
Statistical analysis
Data are expressed as the mean ± SD of three 
independent determinations, and significance was 
analyzed using the t-test and one-way ANOVA. *P < 0.05 
was considered statistically significant. All analyses were 
performed using the Statistical Package for the Social 
Sciences (SPSS) statistical software for Windows, Version 
18.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Effect of icariin on cell viability 
The effect of icariin on cell viability of BM-MSCs 
was determined by MTT assay. As shown in Figure 
1, 0.001 μM icariin had no significant effect on the 
proliferation of BM-MSCs. However, icariin at 0.01, 0.1, 
or 1 μM promoted MSC proliferation (P < 0.01), and 
showed a quantitative relationship. Meanwhile, 10 μM 
of icariin showed a certain cytotoxicity, significantly 
inhibiting the proliferation of BM-MSCs (P < 0.05).
Assessment of ALP activity under different 
treatment conditions
BM-MSCs were treated with different concentrations 
of icariin for 24 h. the groups treated with 0.01, 0.1, or 1 
μM icariin showed a significant increase in ALP activity 
compared with the control group (P< 0.05, Figure 2 A).
Icariin administration enhanced BM-MSC gene 
and protein expression via the cAMP/PKA/CREB 
signaling pathway
The cAMP/PKA/CREB signaling pathway has 
been shown to play an important role in differentiation 
of BM-MSCs. To determine the mechanism of icariin on 
BM-MSC differentiation, we examined the effect of icariin 
on the expression of components of the cAMP/PKA/
CREB signaling pathway. Our qPCR data showed that 
icariin significantly enhanced mRNA expression of CREB 
and PKA in BM-MSCs. As shown in Figure 2, treatment 
with icariin at a concentration of 1 μM induced the most 
significant effect with a 1.9-fold increase in expression of 
CREB and a 1.6-fold increase in PKA, compared to the 
blank group (0 μM). The effect of icariin on BM-MSC 
mRNA expression showed a dose-response relationship 
(Figure 2. C, D). Finally we examined the effect of icariin 
on protein expression of PKA/CREB signaling molecules, 
and found that icariin stimulation of BM-MSCs showed 
a dose-response relationship. Expression of PKA/CREB 
was significant increased after treatment with icariin 
at the concentration of 1 μM, including both mRNA 
and protein levels (Figure 2 B). Taken together, these 
FIGURE 1 - Effects of different concentrations of icariin on the 
proliferation of BM-MSCs at 24 h. vs. treatment with 0 μM, 
*P < 0.05, **P < 0.01.
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results demonstrate that icariin may regulate BM-MSC 
differentiation through activation of the cAMP/PKA/
CREB signaling pathway.
Icariin induced BMP2, Smad1, and RUNX2 mRNA 
and protein expression in BM-MSCs
The CREB receptors BMP2, Smad1, and Runx2 
were constitutively expressed on BM-MSCs (Figure 3). 
The mRNA and protein levels of BMP2, Smad1, and 
Runx2 were analyzed after treatment of BM-MSCs with 
icariin to determine whether icariin increased BMP2, 
Smad1, and Runx2 expression. Analysis by RT-PCR 
showed that BM-MSCs treated with icariin exhibited a 
significant and dose-dependent increase in the mRNA 
expression of BMP2, Smad1, and Runx2, compared with 
untreated cells (Figure 3 A–C). The effect of icariin on 
BMP2, Smad1, and Runx2 protein expression was also 
dose-dependent. Meanwhile, the mRNA and protein 
expression of BMP2, Smad1, and RUNX2 showed 
a significantly greater sensitivity to icariin (1 μM) 
stimulation than untreated cells (all P < 0.01).
DISCUSSION
The herb Epimedium  has long been used in 
traditional Chinese medicine to treat bone fractures 
and prevent osteoporosis. Researchers believe that 
the flavonoids contained in the herb are the effective 
component responsible for this activity. Icariin should 
be an effective agent for bone-strengthening activity, and 
one of its mechanisms is to stimulate the proliferation 
and enhance the osteogenic differentiation of MSCs 
(Chen et al., 2005). Icariin has been shown to increase 
osteogenic differentiation and mineralization of BMSCs 
and osteoblasts, and to inhibit osteoclast formation and 
bone resorption activity (Zhang et al., 2011; Ma et al., 
2014; Zhang et al., 2016). In this paper, we found that 
low concentrations (0.01, 0.1, 1 μM) of icariin stimulated 
BM-MSC proliferation (P < 0.01), but that 10 μM icariin 
had a certain cytotoxicity, and significantly inhibited the 
proliferation of BM-MSCs (P < 0.05).
Hormones that stimulate the synthesis of cAMP 
regulate many cell type-specific processes including 
gene transcription, cell proliferation, differentiation, 
FIGURE 2 - Icariin actives the cAMP/PKA/CREB signaling pathway in BM-MSCs. (A) Icariin showed a dose-dependent effect 
on alkaline phosphatase (ALP) activity in BM-MSCs. (B) WB analysis showed that icariin treatment of BM-MSCs significantly 
enhanced protein expression of PKA and CREB. (C)(D) RT-PCR results showed that icariin dose-dependently increased the mRNA 
levels of PKA and CREB in BM-MSCs. vs. treatment with 0 μM, *P < 0.05, **P < 0.01.
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and survival. These processes are mediated, in part, by 
the MAP (mitogen-activated protein) kinase (or ERK; 
extracellular signal response kinase) cascade in a wide 
range of diverse cell types including pancreatic islet 
cells, bone cells, pituitary cells, thyroid cells, neuronal 
cells and others (Li et al., 2016). In this study, we 
found that cAMP consistently enhanced the expression 
of the osteogenesis marker ALP. The results of cell 
proliferation assay demonstrated that icariin stimulated 
BM-MSC proliferation. These results indicated that 
icariin treatment at different concentrations promoted 
proliferation of BM-MSCs through the cAMP/PKA/
CREB pathway. Further, we sought to examine the effect 
of icariin on expression of PKA/CREB mRNA and 
protein, by analyzing the mRNA and protein levels of 
PKA/CREB after treatment of BM-MSCs. Analysis using 
RT-PCR and WB showed that BM-MSCs treated with 
icariin exhibited a dose-dependent increase in the mRNA 
and protein expression of PKA/CREB, compared with 
untreated cells. Several previous studies have evaluated 
the role of the PKA pathway in osteogenic differentiation 
of hMSCs, and reported that pretreatment of human 
MSCs with a cAMP analog or forskolin enhanced bone 
formation. cAMP is a pivotal intracellular signaling 
molecule, the main function of which is to activate 
cAMP-dependent PKA (Yang et al., 2008). Adenylate 
cyclase is activated through dissociation of G-proteins, 
causing the conversion of adenosine triphosphate into 
cAMP. Subsequently, cAMP activates PKA, which in turn 
phosphorylates CREB protein, and this translocates into 
the nucleus where it activates transcription of target genes 
( Kim et al., 2013; Chen et al., 2016). However, precisely 
how the administration of icariin regulates osteogenic 
differentiation of BM-MSCs by the cAMP/PKA/CREB 
signaling pathway requires further elucidation. In the 
current study, cell proliferation assays, osteogenic gene 
expression testing, and ALP activity detection were used 
in order to determine the underlying molecular mechanism 
by which icariin administration modulates the cAMP/
PKA/CREB signaling pathway.
Previous studies have shown that activation of the 
PKA pathway synergistically participates in BMP-2-
induced osteoblastic differentiation, possibly by mediating 
the CREB and/or Ras/MAPK pathways, and activation of 
the PKA pathway may be one of the key BMP-2-activated 
signaling events that lead to osteogenic differentiation 
FIGURE 3 - Icariin induced BM-MSC differentiation by BMP2, Smad1, and Runx2. RT-PCR and WB results indicated that icariin 
significantly increased the expression of BMP2, Smad1, and Runx2 in BM-MSCs. vs. treatment with 0 μM; *P < 0.05, **P < 0.01
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(Zhao et al., 2006). Based on these findings, we also tested 
the mRNA and protein expression of BMP2, Smad1, and 
Runx2 in BM-MSCs stimulated with icariin to investigate 
whether the administration of icariin regulates osteogenic 
differentiation of BM-MSCs via the cAMP/PKA/CREB 
signaling pathway. BMP/Smad signals are mediated 
by BMP receptors (type I and II). Smad1, 5, and 8 are 
phosphorylated by the BMP receptors and form a complex 
with Smad4, following which the complex is translocated 
into the nucleus. Within the nucleus, the phosphorylated 
Smads interact with other transcription factors such as 
Runx2 to initiate transcription of osteogenic-related genes 
(Xu et al., 2015). We focused on signaling pathways 
involved in icariin-mediated BMP2, Smad1, and Runx2 
expression in BM-MSCs according to previous reports 
(Guo et al., 2016; Su et al., 2015). Analysis by RT-PCR 
and WB showed that BMP2, Smad1, and Runx2 were 
activated by icariin in BM-MSCs (Figure 3). Taken 
together, our results indicate that icariin regulates the 
expression of BMP2 in BM-MSCs through the cAMP/
PKA/CREB signaling pathway.
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